← back to search

Zuzana Walker

Université Claude Bernard Lyon 1 · FR
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research focused on Dementia and Dementia with Lewy bodies, with related work in Mental health, Positron emission tomography, Translocator protein. Notable publications include 'Research criteria for the diagnosis of prodromal dementia with Lewy bodies', 'Lewy body dementias', and 'Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density'.
h-index
citations
4,335
works
34
NIH funding
primary concept
email

Recent publications

Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial
Nature Medicine 2025cited by 22position: middledoi
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study
Alzheimer s & Dementia 2024cited by 27position: middledoi
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
Journal of Nuclear Medicine 2024cited by 26position: middledoi
Cerebrovascular and Alzheimer’s disease biomarkers in dementia with Lewy bodies and other dementias
Brain Communications 2024cited by 19position: middledoi
Predicting progression to Alzheimer's disease dementia using cognitive measures
International Journal of Geriatric Psychiatry 2024cited by 15position: lastdoi
Quantification supports amyloid-PET visual assessment of challenging cases: results from the AMYPAD-DPMS study
medRxiv 2024cited by 4position: middledoi
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients
JAMA Neurology 2023cited by 36position: middledoi
Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
JAMA Network Open 2023cited by 33position: middledoi
Sex differences in brain atrophy in dementia with Lewy bodies
Alzheimer s & Dementia 2023cited by 23position: middledoi
Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults
Neurology 2022cited by 18position: middledoi
Evaluation of liraglutide in the treatment of Alzheimer's disease
Alzheimer s & Dementia 2021cited by 68position: middledoi
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
Alzheimer s Research & Therapy 2021cited by 55position: middledoi
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
Neurology 2020cited by 763position: middledoi
Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 65position: middledoi
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
Trials 2019cited by 211position: middledoi
Clinical effectiveness of the START (STrAtegies for RelaTives) psychological intervention for family carers and the effects on the cost of care for people with dementia: 6-year follow-up of a randomised controlled trial
The British Journal of Psychiatry 2019cited by 59position: middledoi
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
European Journal of Neurology 2018cited by 211position: middledoi
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium
Alzheimer s & Dementia 2018cited by 96position: middledoi
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
European Journal of Nuclear Medicine and Molecular Imaging 2018cited by 58position: middledoi
Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study
The British Journal of Psychiatry 2018cited by 41position: middledoi
Predictors of Age of Diagnosis and Survival of Alzheimer’s Disease in Down Syndrome
Journal of Alzheimer s Disease 2017cited by 134position: middledoi
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2017cited by 92position: middledoi
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
Journal of Alzheimer s Disease 2017cited by 91position: middledoi
Lewy body dementias
The Lancet 2015cited by 581position: firstdoi
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
JAMA Neurology 2015cited by 334position: middledoi
START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
Health Technology Assessment 2014cited by 190position: middledoi
Effective radiation dose and eye lens dose in dental cone beam CT: effect of field of view and angle of rotation
British Journal of Radiology 2014cited by 101position: middledoi
Long-term clinical and cost-effectiveness of psychological intervention for family carers of people with dementia: a single-blind, randomised, controlled trial
The Lancet Psychiatry 2014cited by 96position: middledoi
A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)
Journal of the American Medical Directors Association 2014cited by 33position: lastdoi
Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial
BMJ 2013cited by 228position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claudia Cooper · Anglia Ruskin University5 papers (2013–2019)Cath Mummery · UK Dementia Research Institute5 papers (2013–2019)Penny Rapaport · University of London5 papers (2013–2019)Juanita Hoe · University of London5 papers (2013–2019)Julie Barber · University of Idaho5 papers (2013–2019)Gill Livingston · Central and North West London NHS Foundation Trust5 papers (2013–2019)Renée Romeo · King's College London4 papers (2013–2019)Dag Aarsland · Transnational Press London4 papers (2014–2018)Flavio Nobili · Indiana University School of Medicine4 papers (2017–2018)Alexander Drzezga · Forschungszentrum Jülich4 papers (2018–2024)C Theodorakou · University of Manchester3 papers (2012–2014)Ria Bogaerts · KU Leuven3 papers (2012–2014)Keith Horner · University of Manchester3 papers (2012–2014)Daniele Altomare · University of Applied Sciences and Arts of Southern Switzerland3 papers (2018–2024)Ruben Pauwels · KU Leuven3 papers (2012–2014)David Thomas · Tulane University2 papers (2017–2018) · 2 papers (2017–2018)Robin Wolz · Ixico (United Kingdom)2 papers (2024–2024)Giovanni B. Frisoni · University of Geneva2 papers (2024–2024) · 2 papers (2017–2018)